Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03887299 · ClinicalTrials.gov registry record · Phase 4
Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery
A Phase 4 study, sponsored by The University of Texas Medical Branch, Galveston.
- Completed
- Registry status
- Phase 4
- Development phase
- 154
- Enrollment target
NCT03887299 is a Phase 4 study that has completed, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 154 participants.
The verdict
NCT03887299, a Phase 4 study, has completed, sponsored by The University of Texas Medical Branch, Galveston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 154 participants
- Enrollment target
Study Summary
This will be an open label pilot randomized controlled clinical trial. Women undergoing cesarean delivery will be randomized to have standard wound dressing care or chlorohexidine gluconate (CHG) impregnated wound dressing (ReliaTect™ Post-Op Dressing).
Interventions
- COMBINATION_PRODUCT ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG)
- OTHER Standard Wound Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2019-04-18 |
| Est. Completion | 2020-02-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03887299
The ClinicalTrials.gov registry entry for NCT03887299 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG) is the first listed.
NCT03887299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03887299 about?
NCT03887299 is a clinical study titled "Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery". This will be an open label pilot randomized controlled clinical trial. Women undergoing cesarean delivery will be randomized to have standard wound dressing care or chlorohexidine gluconate (CHG) impregnated wound dressing (ReliaTect™ Post-Op Dressing).
What is the current status of trial NCT03887299?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 154 participants. The study started on 2019-04-18. Estimated completion is 2020-02-28.
What interventions are being tested in trial NCT03887299?
The interventions under investigation include: ReliaTect™ Post-Op Dressing (contains chlorohexidine gluconate or CHG) (COMBINATION_PRODUCT), Standard Wound Care (OTHER).
Who is sponsoring clinical trial NCT03887299?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.